Hye-Yeon Kim
Chief Executive Officer chez PHARMGEN SCIENCE, INC.
Fortune : 125 595 $ au 31/03/2024
Profil
Hye-Yeon Kim is currently the Co-CEO, Director, and Head of Research & Development at PharmGen Science, Inc. He previously worked as an Executive Board Member at DAE HWA PHARM Co., Ltd.
Kim received his undergraduate degree from Ewha Womans University, his graduate degree from the University of Kansas, and his doctorate from Sungkyunkwan University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMGEN SCIENCE, INC.
0,16% | 11/04/2024 | 29 979 ( 0,16% ) | 125 595 $ | 31/03/2024 |
Postes actifs de Hye-Yeon Kim
| Sociétés | Poste | Début |
|---|---|---|
| PHARMGEN SCIENCE, INC. | Chief Executive Officer | - |
Anciens postes connus de Hye-Yeon Kim
| Sociétés | Poste | Fin |
|---|---|---|
| DAE HWA PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
Formation de Hye-Yeon Kim
| University of Kansas | Graduate Degree |
| Ewha Womans University | Undergraduate Degree |
| Sungkyunkwan University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PHARMGEN SCIENCE, INC. | Health Technology |
| DAE HWA PHARMACEUTICAL CO., LTD. | Health Technology |
